IQVIA Holdings Inc. (IQV) Stock Price
IQVStock
$261.75+38.69%52W
Market Cap$43.08B
P/E28.96x
PEG Ratio1.08
Div yield—
Beta1.19
IQV Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)46.82%
Price vs S&P 500 (4W)10.62%
PEG Ratio1.08
VGM Score59.25
P/E Ratio (Annual)28.96x
IQV Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $3.03 | $3.15 | +3.94%(+$0.12) | |
| Q1 2026 | $2.82 | $2.90 | +2.96%(+$0.08) | |
| Q4 2025 | $3.40 | $3.42 | +0.69%(+$0.02) | |
| Q3 2025 | $2.98 | $3.00 | +0.81%(+$0.02) | |
| Q2 2025 | $2.77 | $2.81 | +1.43%(+$0.04) |
IQV Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.19
4.10
4.03
4.07
Industry Peers — R&D — Physical Sciences(16)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IQVIQVIA Holdings Inc. | D | C | A | $261.75 |
| INCYIncyte Genomics Inc | C | A | B | $124.37 |
| MEDPMedpace Holdings, Inc. Common Stock | F | B | B | $600.65 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $291.50 |
| ICLRIcon Plc | C | C | B | $170.02 |
| ABSIAbsci Corporation Common Stock | F | F | A | $8.71 |
| OABIOmniAb, Inc. Common Stock | D | C | A | $4.47 |
| NRCNRC Health Common Stock | D | D | B | $21.85 |
| MXCTMaxCyte, Inc. Common Stock | C | D | C | $1.22 |
| IBACIB Acquisition Corp. Common Stock | — | D | C | $10.89 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | D | $0.58 |
About IQVIA Holdings Inc.
IQVIA provides outsourced clinical trial services and healthcare data analytics to the global pharmaceutical and healthcare industries. The company operates through two segments: Research & Development, offering late-stage clinical trials to pharmaceutical, medical device, and diagnostic companies; and Technology & Analytics, delivering aggregated data and analytics solutions to pharmaceutical firms, healthcare providers, payers, and policymakers.